News – Page 135 – Endpoints News

Lilly’s Zepbound resolves sleep apnea in obese patients, furthering case for label expansion

11 months ago

Bristol Myers wins approval for KRAS drug Krazati in colorectal cancer

11 months ago

FDA ships two Form 483s to Dr. Reddy’s for two separate sites in India

11 months ago

Layoffs at Ginkgo and Xellia; Melodia and Alivexis ink $275M partnership

11 months ago

Lexicon resubmits type 1 diabetes drug to FDA five years after rejection

11 months ago

The Endpoints Slack interview: Saji Wickramasekara on where AI misses the mark — and what's next for Benchling

11 months ago

Obesity care startup knownwell buys an AI weight loss platform

11 months ago

US, EU pledge $2B+ to help boost vaccine manufacturing in Africa

11 months ago

Moncef Slaoui joins board at mRNA biotech; Gamida Cell retools with ex-Amryt CEO at the helm

11 months ago

FDA widens Sarepta’s Duchenne gene therapy label to older boys in significant expansion of use

11 months ago

Tectonic enters public markets in one of few biotech reverse mergers this year

11 months ago

Gilead's twice-a-year injection fully prevented HIV in Phase 3 study with cisgender women

11 months ago

Scientists just discovered a new genetic clue for delaying Alzheimer’s disease. It’s already inspiring drug ...

11 months ago

Zealand Pharma hits early efficacy goal for amylin weight loss candidate

11 months ago

FDA to pharma companies: Using CRO Synapse's studies 'unacceptable'

11 months ago

CBER chief floats rare disease hub to better communicate across centers

11 months ago

Takeda budgets $230M for plasma therapy facility expansion in California

11 months ago

Another fire breaks out at a Novo Nordisk site; Thermo Fisher earmarks $58M into a new lab

11 months ago

Corrected: Emergent sells Baltimore facility for $30M

11 months ago

Jazz's stock dips after mid-stage fail in essential tremor

11 months ago

PTC touts Phase 2 biomarker data for Huntington’s drug, showing dose-dependent effect at one year

11 months ago

FDA makes it easier for biosimilars to obtain interchangeability designations

11 months ago

Silence’s siRNA candidate for cardiovascular disease continues to deliver in Phase 2 trial

11 months ago

Forbion's new €75M fund; Cara Therapeutics to cut workforce after trial failure

11 months ago

First page Previous page 132 133 134135136 137 138 Next page Last page